Marlen C Lauffer (Marlen Lauffer)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Peritoneal Dialysis

Chronic Kidney Disease

Top Venues

RNA (New York, N.Y.)

Communications medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Marlen C Lauffer, Willeke van Roon-Mom, Annemieke Aartsma-Rus, null null
Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders. Communications medicine 4 (1) (2024)
Marlen C Lauffer, Willeke van Roon-Mom, Annemieke Aartsma-Rus, null null
Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders. Communications medicine 4 (1) (2024)
Annemieke M Aartsma-Rus, Willeke M C van Roon-Mom, Marlen C Lauffer, Christine Siezen, Britt Duijndam, Tineke Coenen-de Roo, Rebecca Schüle, Matthis Synofzik, Holm Graessner
Development of tailored splice switching oligonucleotides for progressive brain disorders in Europe: development, regulation and implementation considerations. RNA (New York, N.Y.) (2023)
Annemieke M Aartsma-Rus, Willeke M C van Roon-Mom, Marlen C Lauffer, Christine Siezen, Britt Duijndam, Tineke Coenen-de Roo, Rebecca Schüle, Matthis Synofzik, Holm Graessner
Development of tailored splice-switching oligonucleotides for progressive brain disorders in Europe: development, regulation, and implementation considerations. RNA (New York, N.Y.) 29 (4) (2023)
Annemieke M Aartsma-Rus, Willeke M C van Roon-Mom, Marlen C Lauffer, Christine Siezen, Britt Duijndam, Tineke Coenen-de Roo, Rebecca Schüle, Matthis Synofzik, Holm Graessner
Development of tailored splice-switching oligonucleotides for progressive brain disorders in Europe: development, regulation, and implementation considerations. RNA (New York, N.Y.) 29 (4) (2023)
Annemieke M Aartsma-Rus, Willeke M C van Roon-Mom, Marlen C Lauffer, Christine Siezen, Britt Duijndam, Tineke Coenen-de Roo, Rebecca Schüle, Matthis Synofzik, Holm Graessner
Development of tailored splice-switching oligonucleotides for progressive brain disorders in Europe: development, regulation, and implementation considerations. RNA (New York, N.Y.) 29 (4) (2023)
Annemieke M Aartsma-Rus, Willeke M C van Roon-Mom, Marlen C Lauffer, Christine Siezen, Britt Duijndam, Tineke Coenen-de Roo, Rebecca Schüle, Matthis Synofzik, Holm Graessner
Development of tailored splice-switching oligonucleotides for progressive brain disorders in Europe: development, regulation, and implementation considerations. RNA (New York, N.Y.) 29 (4) (2023)